NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia

IntroductionAcute myeloid leukemia (AML) is an aggressive blood cancer with high heterogeneity and poor prognosis. Although the metabolic reprogramming of nicotinamide adenine dinucleotide (NAD) has been reported to play a pivotal role in the pathogenesis of acute myeloid leukemia (AML), the prognos...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yuncan Cao, Wenjing Shu, Peng Jin, Jianfeng Li, Hongming Zhu, Xinjie Chen, Yongmei Zhu, Xi Huang, Wenyan Cheng, Yang Shen
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-06-01
Col·lecció:	Frontiers in Immunology
Matèries:	acute myeloid leukemia NAD metabolism prognostic signature immune microenvironment targeted therapy
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1417398/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!